NCT03324113 - Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 17, 2017

Primary Completion Date

November 18, 2022

Study Completion Date

December 26, 2022

Conditions

Neoplasm Malignant

Interventions

DRUG

SAR408701

"Pharmaceutical form: solution for infusion~Route of administration: intravenous"

DRUG

dexamethasone

"Pharmaceutical form: solution for eye drop~Route of administration: eye drop"

DRUG

naphazoline

"Pharmaceutical form: solution for eye drop~Route of administration: eye drop"

DRUG

diphenhydramine

"Pharmaceutical form: tablet~Route of administration: oral"

Trial Locations (3)

Investigational Site Number : 3920002, Nagoya

Investigational Site Number : 3920003, Kashiwa-shi

Investigational Site Number : 3920001, Sunto-gun